Droplet-microfluidics-assisted sequencing of HIV proviruses and their integration sites in cells from people on antiretroviral therapy

Chen Sun,Leqian Liu,Liliana Pérez,Xiangpeng Li,Yifan Liu,Peng Xu,Eli A. Boritz,James I. Mullins,Adam R. Abate

DOI: https://doi.org/10.1038/s41551-022-00864-8

IF: 28.1

2022-03-28

Nature Biomedical Engineering

Abstract:Nature Biomedical Engineering, Published online: 28 March 2022; doi:10.1038/s41551-022-00864-8HIV proviruses and their adjacent host DNA junctions can be assembled via high-throughput droplet-based whole-genome amplification followed by a polymerase chain reaction to tag droplets containing proviruses for sequencing.

engineering, biomedical

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: how to effectively and comprehensively analyze the provirus in latently infected cells and its integration sites during antiretroviral therapy (ART) of the human immunodeficiency virus (HIV). Specifically, the paper aims to overcome the challenges encountered by existing technologies in amplifying and sequencing these rare proviruses, especially when these proviruses exist in a large amount of the human genome background.

### Core of the problem:
1. **Persistence of the HIV latent reservoir**: Although ART can suppress HIV replication to undetectable levels, it cannot clear the latent provirus reservoir, and these proviruses can be re - activated after treatment cessation and lead to virus rebound.
2. **Limitations of existing methods**: Current methods (such as nested PCR) can partially recover provirus sequences, but it is difficult to obtain the complete provirus genome and its integration site with the host genome simultaneously, and it is also prone to artifacts and biases.
3. **Isolation and analysis of rare infected cells**: Since the infected CD4+ T cells are very scarce, existing methods need to process a large number of cell samples and are prone to introduce multiple amplifications, thus affecting the accuracy of the results.

### New method proposed in the paper:
To overcome the above problems, the paper introduces a new high - throughput microfluidic technology - **SIP - seq (Simultaneous Integration Site and Provirus sequencing)**. This method achieves efficient and accurate sequencing of the provirus and its integration sites through the following steps:

1. **Microfluidic droplet encapsulation**: DNA fragments containing HIV proviruses are encapsulated in microfluidic droplets, with each droplet containing one provirus.
2. **Whole - genome amplification (MDA)**: Non - specific whole - genome amplification is carried out in each droplet to ensure that there are sufficient amplification products for subsequent sequencing.
3. **TaqMan PCR labeling**: TaqMan PCR is used to label the droplets containing HIV proviruses, and these droplets are identified and separated by fluorescence signals.
4. **Barcode labeling and sequencing**: The isolated droplets are barcode - labeled and sequenced, and finally the complete provirus genome and its integration site with the host genome are obtained.

### Main contributions:
- **High sensitivity and specificity**: The SIP - seq method can efficiently isolate and sequence rare HIV proviruses from millions of CD4+ T cells, avoiding the multiple amplification problem in traditional methods.
- **Complete genome and integration site information**: This method can obtain the complete provirus genome and its integration site with the host genome simultaneously, which is crucial for understanding the genetic diversity and persistence of the HIV latent reservoir.
- **Wide application**: SIP - seq is not only applicable to HIV research, but can also be extended to the research of other viruses inserted into the host genome.

Through this method, researchers can gain a deeper understanding of the genetic characteristics of the HIV latent reservoir and provide important scientific basis for the development of more effective cure strategies.